Lisbet Brandi
Clinical Associate Professor
26 - 28 out of 28Page size: 25
- 2009
- Published
Treatment of secondary hyperparathyroidism in haemodialysis patients: a randomised clinical trial comparing paricalcitol and alfacalcidol
Hansen, Ditte, Brandi, Lisbet & Rasmussen, K., 2009, In: BMC Nephrology. 10, p. 28Research output: Contribution to journal › Journal article › Research › peer-review
- 2008
- Published
One-alpha-hydroxy-cholecalciferol - an active vitamin D analog
Brandi, Lisbet, 2008, København: Maanedsskrift for Praktisk Laegegerning. 103 p.Research output: Book/Report › Ph.D. thesis › Research
- 1996
- Published
Long-term effects of intravenous 1 alpha (OH)D3 combined with CaCO3 and low-calcium dialysis on secondary hyperparathyroidism and biochemical bone markers in patients on chronic hemodialysis
Brandi, Lisbet, Daugaard, H., Nielsen, P. K., Jensen, Lars Thorbjørn, Egsmose, C. & Ølgaard, Klaus, 1996, In: Nephron Clinical Practice. 74, 1, p. 89-103 15 p.Research output: Contribution to journal › Journal article › Research › peer-review
ID: 11221128
Most downloads
-
190
downloads
A Retrospective Quality Study of Hemodialysis Catheter-Related Bacteremia in a Danish Hospital
Research output: Contribution to journal › Journal article › Research › peer-review
Published -
184
downloads
Alfacalcidol in CKD-MBD: A Fresh Look
Research output: Contribution to journal › Review › Research › peer-review
Published -
159
downloads
The Effect of High Dose Cholecalciferol on Arterial Stiffness and Peripheral and Central Blood Pressure in Healthy Humans: A Randomized Controlled Trial
Research output: Contribution to journal › Journal article › Research › peer-review
Published